A. Mendelsohn

发表

Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle.

M. Dick, R. Beekman, E. Bove, 1993, The American journal of cardiology.

Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Stanley B. Cohen, D. Symmons, M. Dougados, 2011 .

Hemodynamic and clinical effects of oral levodopa in children with congestive heart failure.

R. Beekman, A. Mendelsohn, C. Johnson, 1997, Journal of the American College of Cardiology.

Hepatic venous malformation after modified Fontan procedure with partial hepatic vein exclusion.

W. Norwood, D. Schneider, A. Mendelsohn, 1997, The Annals of thoracic surgery.

Stent redilation in canine models of congenital heart disease: pulmonary artery stenosis and coarctation of the aorta.

C. Moorehead, R. Beekman, A. Ludomirsky, 1996, Catheterization and cardiovascular diagnosis.

Transcatheter closure of a patent foramen ovale following mitral valve replacement.

R. Skulski, A. Mendelsohn, F. Ling, 1999, The Annals of thoracic surgery.

Early open radical commissurotomy: surgical treatment of choice for mitral stenosis.

F. Spencer, J. Cunningham, A. Mendelsohn, 1982, The Annals of thoracic surgery.

Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from two phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).

A. Gottlieb, M. Lebwohl, N. Mehta, 2020, Journal of the American Academy of Dermatology.

Late follow-up of balloon angioplasty in children with a native coarctation of the aorta.

R. Beekman, A. Mendelsohn, S. Sandhu, 1994, The American journal of cardiology.

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate‐to‐severe chronic plaque psoriasis

Y. Poulin, A. Mendelsohn, S. Rozzo, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Kavanaugh, A. et al. (2014) Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT

A. Gottlieb, P. Rahman, I. McInnes, 2014 .

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled,

A. Gottlieb, P. Rahman, I. McInnes, 2014, Annals of the rheumatic diseases.

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

C. Wouters, P. Woo, E. Silverman, 2009, Annals of the rheumatic diseases.

Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status

Yang Zhao, S. Feldman, A. Mendelsohn, 2019, The Journal of dermatological treatment.

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial

R. Saurenmann, R. Petty, P. Woo, 2010, Pediatric rheumatology online journal.

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States.

R. Gerber, Amitabh Singh, A. Mendelsohn, 2016, Journal of managed care & specialty pharmacy.

Transcatheter Occlusion of Patent Ductus Arteriosus With Gianturco Coils

R. Beekman, A. Mendelsohn, S. Sandhu, 1993, Circulation.

Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials

A. Menter, R. Bissonnette, L. Puig, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Balloon angioplasty for native coarctation of the aorta.

A. Mendelsohn, 1995, Journal of interventional cardiology.

Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis

Yang Zhao, B. Elewski, A. Menter, 2020, The Journal of dermatological treatment.

Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64‐week phase 3 study (reSURFACE 1)

H. Nakagawa, M. Honma, M. Ohtsuki, 2021, The Journal of dermatology.

Natural history of isolated atrial flutter in infancy.

M. Dick, A. Mendelsohn, G. Serwer, 1991, The Journal of pediatrics.

Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States

Yang Zhao, S. Feldman, A. Armstrong, 2020, The Journal of dermatological treatment.

Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis

B. Elewski, M. Gooderham, A. Mendelsohn, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Is echocardiography or magnetic resonance imaging superior for precoarctation angioplasty evaluation?

A. Mendelsohn, L. Donnelly, A. Banerjee, 1997, Catheterization and cardiovascular diagnosis.

Inroads in transcatheter therapy for congenital heart disease.

A. Mendelsohn, D. Shim, D. Shim, 1998, The Journal of pediatrics.

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

K. Reich, K. Gordon, Y. Poulin, 2020, The Journal of dermatological treatment.

Outcomes of pregnancies from the tildrakizumab phase I–III clinical development programme

T. Bhutani, A. Mendelsohn, S. Rozzo, 2020, The British journal of dermatology.

Real-world biologic and apremilast treatment patterns and healthcare costs in moderate-to-severe plaque psoriasis.

Yang Zhao, S. Feldman, A. Mendelsohn, 2021, Dermatology online journal.

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

A. Gottlieb, P. Rahman, P. Mease, 2021, Annals of the Rheumatic Diseases.

Radiography of thoracic intravascular stents in children with congenital heart disease

E. Caoili, R. Beekman, E. Bove, 2005, Pediatric Radiology.

Coarctation of the aorta following coil occlusion of a patent ductus arteriosus.

A. Mendelsohn, D. Shim, T. Kimball, 1998, Catheterization and cardiovascular diagnosis.

Atrial septal defect occlusion with the buttoned device (a multi-institutional U.S. trial).

E. Sideris, R. Beekman, A. Mendelsohn, 1994, The American journal of cardiology.

AB0400 Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: 2-Year Results of A Phase 3 TRIAL of Intravenous Golimumab

M. Weinblatt, R. Westhovens, A. Mendelsohn, 2014 .

Intraoperative and Percutaneous Stenting of Congenital Pulmonary Artery and Vein Stenosis

R. Beekman, E. Bove, A. Mendelsohn, 1993, Circulation.

Initial results of the US. PFO/ASD closure trial

Z. Hijazi, M. O'Laughlin, A. Mendelsohn, 1996 .

Central pulmonary artery growth patterns after the bidirectional Glenn procedure.

R. Beekman, E. Bove, A. Mendelsohn, 1994, The Journal of thoracic and cardiovascular surgery.

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

A. Gottlieb, A. Menter, A. Kavanaugh, 2009, The Lancet.

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

A. Gottlieb, P. Rahman, I. McInnes, 2014, Annals of the rheumatic diseases.

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

A. Gottlieb, P. Rahman, I. McInnes, 2013, The Lancet.

The burden of psoriatic arthritis: a literature review from a global health systems perspective.

A. Mendelsohn, Seina P. Lee, E. Sarnes, 2010, P & T : a peer-reviewed journal for formulary management.

Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial

A. Gottlieb, A. Menter, A. Kavanaugh, 2010, Current medical research and opinion.

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

A. Gottlieb, P. Rahman, I. McInnes, 2015, Arthritis care & research.

Ustekinumab Treatment and Improvement of Physical Function and Health‐Related Quality of Life in Patients With Psoriatic Arthritis

A. Gottlieb, P. Rahman, I. McInnes, 2016, Arthritis care & research.

OP0230 EFFICACY AND SAFETY OF TILDRAKIZUMAB, A HIGH-AFFINITY ANTI–INTERLEUKIN-23P19 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 2B STUDY

A. Gottlieb, A. Orbai, P. Rahman, 2020 .

OP0079 Ustekinumab is Effective in Inhibiting Radiographic Progression in Patients with Active Psoriatic Arthritis: Integrated Data Analysis of Two Phase 3, Randomized, Placebo-Controlled Studies

I. McInnes, A. Kavanaugh, M. Song, 2014 .

SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

I. McInnes, A. Kavanaugh, M. Song, 2014 .

OP0158 Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study

P. Rahman, I. McInnes, A. Kavanaugh, 2013 .

Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials

M. Gooderham, K. Papp, K. Reich, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Determinants of successful balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum.

R. Beekman, A. Mendelsohn, T. Lloyd, 1995, Journal of the American College of Cardiology.

Predictors of successful pulmonary balloon valvuloplasty: 10-year experience.

A. Mendelsohn, R. Meyer, D. Schwartz, 1996, Catheterization and cardiovascular diagnosis.

Balloon valvuloplasty: Shedding additional light: Reply to the letter to the editor by Mario Cazzaniga

A. Mendelsohn, R. Meyer, A. Banerjee, 1997 .

Double-chambered right ventricle in an adult patient.

A. Mendelsohn, F. Ling, V. Kalaria, 2001, The Journal of invasive cardiology.

Surgical results for mitral regurgitation from coronary artery disease.

P. Cappabianca, J. Cunningham, A. Acinapura, 1986, The Journal of thoracic and cardiovascular surgery.

Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.

J. Kremer, P. Taylor, C. Ritchlin, 2010, Arthritis and rheumatism.

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Yoshiya Tanaka, H. Valdez, C. Nduaka, 2017, Arthritis & rheumatology.

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) *

K. Reich, P. Foley, R. Warren, 2021, The British journal of dermatology.

Rapid progression of aortic aneurysms after patch aortoplasty repair of coarctation of the aorta.

R. Beekman, A. Mendelsohn, D. Crowley, 1992, Journal of the American College of Cardiology.

Mitral Valve Regurgitation

A. Mendelsohn, 2007 .

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

C. Wouters, P. Woo, Z. Balogh, 2008, Pediatric Rheumatology Online Journal.

Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis.

C. Pendley, H. Davis, A. Mendelsohn, 2010, International journal of clinical pharmacology and therapeutics.

The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial

M. Weinblatt, Chenglong Han, C. Bingham, 2014, The Journal of Rheumatology.

Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial

Rene Westhovens, Clifton O Bingham, Michael Mack, 2012, Annals of the rheumatic diseases.

Maintenance of Efficacy and Safety with Subcutaneous Golimumab Among Patients with Active Rheumatoid Arthritis Who Previously Received Intravenous Golimumab

J. Kremer, P. Taylor, C. Ritchlin, 2011, The Journal of Rheumatology.

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

C. Wouters, R. Saurenmann, N. Wulffraat, 2007, Arthritis and rheumatism.

Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

M. Weinblatt, Chenglong Han, C. Bingham, 2015, Arthritis care & research.

A148: A Multi‐Center, Double‐Blind, Randomized‐Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results

C. Wouters, E. Alexeeva, H. Brunner, 2014 .

Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1

W. Liao, A. Mendelsohn, S. Rozzo, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study

M. Menter, A. Mendelsohn, G. Murakawa, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2

M. Lebwohl, N. Mehta, M. Gooderham, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis

Yang Zhao, A. Gottlieb, S. Feldman, 2021, The Journal of dermatological treatment.

Transumbilical balloon angioplasty of subclavian artery thrombosis in a neonate

N. B. Lerner, A. Mendelsohn, F. Ling, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of myocardial hypertrophy on systolic and diastolic function in children: insights from the force-frequency and relaxation-frequency relationships.

T. Knilans, A. Mendelsohn, R. Meyer, 1998, Journal of the American College of Cardiology.

Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study

D. Murrell, L. Castelo-Soccio, A. Mendelsohn, 2023, Dermatology and Therapy.

Ritchlin, C. et al. (2014) Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double

A. Gottlieb, P. Rahman, I. McInnes, 2014 .

Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab, a High-Affinity Anti–Interleukin-23P19 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis

A. Gottlieb, P. Mease, M. Luggen, 2020 .

LB0002 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 2B STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF TILDRAKIZUMAB, A HIGH-AFFINITY ANTI-INTERLEUKIN-23P19 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

P. Mease, M. Luggen, A. Mendelsohn, 2019, Oral Presentations.

OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

I. McInnes, A. Kavanaugh, M. Song, 2015 .

Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis

Yang Zhao, B. Elewski, A. Menter, 2018 .

Clinical and epidemiological research

Rene Westhovens, Clifton O Bingham, Daniel Baker, 2011 .

Atrial Septal Defect Occlusion with the Buttoned Device ( a Multi-Institutional U . Sm Trial )

E. Sideris, R. Beekman, A. Mendelsohn, 2004 .

A. Gottlieb, P. Rahman, I. McInnes, 2014, Annals of the rheumatic diseases.

SAT0267 Safety of Ustekinumab from the Placebo-Controlled Periods of Psoriatic Arthritis and Psoriasis Clinical Developmental Programs

B. Strober, A. Gottlieb, P. Rahman, 2013 .

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States

R. Gerber, Amitabh Singh, A. Mendelsohn, 2016, Journal of managed care & specialty pharmacy.

Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review.

Fioravanti, S. Lipshultz, R. Vermilion, 2000, Progress in pediatric cardiology.

Latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint

Honghui Zhou, Chuanpu Hu, A. Mendelsohn, 2014, Journal of Pharmacokinetics and Pharmacodynamics.

Latent variable indirect response modeling of categorical endpoints representing change from baseline

Honghui Zhou, Zhenhua Xu, Chuanpu Hu, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

The CONTROL study: A randomized, double-blind vehicle-controlled Phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis.

D. Murrell, L. Castelo-Soccio, A. Mendelsohn, 2022, Journal of the American Academy of Dermatology.

AB0398 Efficacy of Adalimumab and Tofacitinib in Rheumatoid Arthritis: Post-Hoc Analyses from A Phase 3 Study

L. Takiya, R. V. van Vollenhoven, R. Fleischmann, 2016 .

Tildrakizumab Efficacy and Safety Are Not Altered by Metabolic Syndrome Status in Patients With Psoriasis: Post Hoc Analysis of 2 Phase 3 Randomized Controlled Studies (reSURFACE 1 and reSURFACE 2).

A. Gottlieb, M. Lebwohl, N. Mehta, 2020, Journal of the American Academy of Dermatology.

Balloon pulmonary valvuloplasty: A differing view. Reply to the letter to the editor by P. Syamasundar Rao

A. Mendelsohn, R. Meyer, A. Banerjee, 1997 .

SAT0563 Long Term Improvements in Physical Function are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients

I. McInnes, A. Kavanaugh, M. Song, 2015 .

The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial

M. Weinblatt, Chenglong Han, C. Bingham, 2014, The Journal of Rheumatology.